ABOUT US

88fa0b_148214f77d5d4e459bbde6d8c2455e2cf

ABOUT US

hemotune AG

hemotune AG is a spin-off company originating out of the Functional Materials Lab at ETH Zurich. hemotune was founded in 2017 and so far raised more than CHF 10 million of funds since incorporation.

Vision

We envision a future where precision blood purification is an indispensable tool to improve patient outcomes and save lives in critical illness and beyond.

Mission

Our mission is to develop breakthrough blood purification technology, enabling revolutionary intervention strategies for the most urgent medical needs and making them accessible for the benefit of patients.

 

MEET THE TEAM

Dr. Inga Nilsson

R&D Chemist

Dr. Monika Dengler

Biomedical Scientist

Lukas Huber

Chemical Process Engineer

 
Dr. Ursina Haltinner

Regulatory & Quality Manager

Dr. Manuel Baumgartner

R&D Engineer

Lorenz Poiger

R&D Engineer

Lukas Langenegger

CEO

Dr. Carlos Mora

CSO

Dr. Jean-Claude Metzger

Head of Product Development

BOARD OF DIRECTORS

Didier Cowling

President of the Board

Perry van Rijsingen

Board Member

 
Lukas Langenegger

CEO & Board Member

Dr. Carlos Mora

CSO & Board Member

ADVISORS

Prof. Dr. Wendelin Jan Stark

Ph.D., ETH Zurich

Prof. Dr. Robert Grass

Ph.D., Turbobeads GmbH

Prof. Dr. Inge Herrmann

Ph.D., Empa & ETH Zurich

 
INVESTORS
Show More
Invest in a life-saving therapy.

You want to know more about our innovation?

© 2020 by hemotune

  • Black LinkedIn Icon
  • Black Twitter Icon
  • YouTube

created by wyssraumdesign